ClinicalTrials.gg
Drug

Isatuximab clinical trials

Also written Sarclisa and SAR650984.

studies test it
73
open now
20
in phase 3
11
first study started
2010

How each study uses isatuximab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the isatuximab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Mar 2020 · SARCLISA · BLA 761113 (FDA, Drugs@FDA)
European Union
30 May 2020 · Sarclisa · EMEA/H/C/004977 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Isatuximab
52
Isatuximab SAR650984
14
Isatuximab-irfc
8
Hu 38SB19
7
Dexamethasone
3

Brand

Sarclisa
37

Development codes

SAR650984
17

Studies by the year they started

72 studies that test it; most in 2021 (12); 1 more planned to start later

Studies that test isatuximab, by start year
YearStudies
20101
20131
20154
20162
20174
20187
20192
20204
202112
202212
202310
20246
20253
20264

Who runs them

Industry 23 · Other 50

Sanofi (21) · Medical College of Wisconsin (3) · University of Heidelberg Medical Center (3) · Canadian Myeloma Research Group (2) · M.D. Anderson Cancer Center (2) · UNC Lineberger Comprehensive Cancer Center (2) · Intergroupe Francophone du Myelome (2) · Thomas Martin, MD (2)

Often tested with

Tested in the same studies.

Dexamethasone (18) · Bortezomib (10) · Lenalidomide (9) · Pomalidomide (6) · Carfilzomib (5) · Iberdomide (3) · Belantamab mafodotin (2) · Cyclophosphamide (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 12, 2 in phase 3

Studies that test isatuximab, phase 3 first.

Studies

Open first, then newest update. How each study uses isatuximab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 73

See all 73 studies that test isatuximab →

Given beside what is tested · 21 — isatuximab is usual care or a partner of the new treatment

Showing 20 of 21.

As the comparator · 1 — what is tested is compared with isatuximab

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call isatuximab · ClinicalTrials.gg INT000257

  • MeSH (NLM) C000599209isatuximabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) R30772KCU0ISATUXIMABConfirmed FDA, NLM, Wikidata
  • RxNorm 2282018Confirmed FDA, Wikidata
  • Wikidata Q20707906isatuximabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C90578IsatuximabOne source FDA
  • DrugBank DB14811One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.